ASCENTAGE PHARMA GROUP INTERNATIONAL

AAPG · NASDAQ
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$1,661,454$1,236,578$1,100,314$1,069,296
Short-Term Investments$0$0$0$0
Receivables$78,362$99,074$852,807$163,540
Inventory$8,591$6,597$10,718$16,167
Other Curr. Assets$160,313$24,633$0$24,537
Total Curr. Assets$1,908,720$1,474,162$1,963,839$1,344,178
Property Plant & Equip (Net)$871,961$905,860$931,183$957,232
Goodwill$24,694$24,694$24,694$24,694
Intangibles$70,994$75,998$79,779$85,446
Long-Term Investments$37,335$33,858$33,204$18,949
Tax Assets$0$44,236$55,073$59,842
Other NC Assets$132,440$59,002$19,298$10,052
Total NC Assets$1,137,424$1,143,648$1,143,231$1,156,215
Other Assets$0$0$0$0
Total Assets$3,046,144$2,617,810$3,107,070$2,500,393
Liabilities
Payables$118,676$91,966$83,083$72,445
Short-Term Debt$822,605$769,623$720,095$606,647
Tax Payable$0$9,627$0$8,389
Deferred Revenue$0$54,085$0$38,410
Other Curr. Liab.$286,843$0$37,485$0
Total Curr. Liab.$1,239,302$1,166,611$1,065,350$934,173
LT Debt$867,111$868,642$959,142$1,166,267
Deferred Rev, NC$0$275,960$270,073$287,549
Deferred Tax Liab, NC$0$5,368$5,849$10,549
Other NC Liab.$248,551$6,274$18,804$18,299
Total NC Liab.$1,130,933$1,177,037$1,265,281$1,495,588
Other Liabilities$0$0$0$0
Cap. Leases$26,449$30,232$20,858$22,681
Total Liabilities$2,370,235$2,343,648$2,330,631$2,429,761
Equity
Pref Stock$0$0$0$0
Common Stock$239$214$214$197
Retained Earnings-$6,361,323-$5,770,555-$5,202,121-$5,365,122
AOCI-$516,067-$510,586-$501,793-$504,461
Other Equity$0$0$0$0
Total Equity$665,997$264,194$766,399$60,417
Supplemental Information
Minority Interest$9,912$9,968$10,040$10,215
Total Liab. & Tot. Equity$3,046,144$2,617,810$3,107,070$2,500,393
Net Debt$28,262$401,687$578,923$703,618
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Financial Statements & Key Stats | AlphaPilot